Howe & Rusling’s Precigen PGEN Stock Holding History

Howe & Rusling’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-240	Closed	-$1K	–	848
2019 Q4	$1K	Hold	240	–	–	﹤0.01%	773
2019 Q3	$1K	Buy	240 +120	+100%	+$815	﹤0.01%	782
2019 Q2	$1K	Buy	+120	New	+$646	﹤0.01%	761

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Howe & Rusling's PGEN Position: Q1 2020 in Review

Howe & Rusling sold out of Precigen (PGEN) in Q1 2020, closing a stake of 240 shares — an estimated $1K sold.

Howe & Rusling first reported a position in PGEN in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 151 funds tracked by Wall St. Rank hold PGEN as of Q1 2020.

Howe & Rusling reported no remaining Precigen position as of Q1 2020 after selling out during the quarter.
Howe & Rusling sold 240 Precigen shares in Q1 2020, an estimated $1K.
Howe & Rusling first reported a position in Precigen in Q2 2019 and held it in 3 quarters.
Howe & Rusling's Precigen position peaked at $1K in Q4 2019.
151 funds tracked by Wall St. Rank held Precigen as of Q1 2020.

Based on Howe & Rusling's 13F filing for Q1 2020, filed 14 May 2020.